✦ LIBER ✦

Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide

✍ Scribed by E. Růžička; H. Línková; M. Pěnička; O. Ulmanová; L. Nováková; J. Roth

Book ID: 106093611
Publisher: Springer
Year: 2007
Tongue: English
Weight: 239 KB
Volume: 254
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-007-0592-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of valvulopathy in Parkinson'

Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline

✍ Gülay Kenangil; Sibel Özekmekçi; Lale Koldas; Taylan Sahin; Ethem Erginöz 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Valvular heart disease in a patient with

Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide

✍ Eun Joo Chung; Won Tae Yoon; Ji-Youn Kim; Won Yong Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

2.229 The effect of pergolide and pramip

2.229 The effect of pergolide and pramipexole on Parkinson tremor in patients with early Parkinson's disease

✍ N. Oztekin; M.F. Oztekin; R. Sarl-Polat; D. Korucu; G. Orhan; F. Ak; M. Saka 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

2.283 The frequency of cardiac valve reg

2.283 The frequency of cardiac valve regurgitation in Japanese patients with Parkinson's disease using pergolide

✍ K. Kimura; T. Sekiguchi; Y. Higashiyama; C. Kugimoto; Y. Baba; S. Koyano; Y. Suz 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Effects of pergolide on nocturia in Park

Effects of pergolide on nocturia in Parkinson's disease: three female cases selected from over 400 patients

✍ Sadako Kuno; Eiji Mizuta; Shunzo Yamasaki; Isao Araki 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Randomized trial of tolcapone versus per

Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations

✍ William Koller; Andrew Lees; Miroslava Doder; Mariese Hely 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

## Abstract In this 12‐week, randomized, open‐label, blinded‐rater, parallel‐group trial, the efficacy, safety, and tolerability of tolcapone and pergolide were compared in parkinsonian patients with a fluctuating response to levodopa. Patients received tolcapone 100 mg three times daily (t.i.d.),